US healthcare commercial leader Hugh Watson joins Nightingale Health as Chief Commercial Officer, Americas

Watson joins Nightingale Health from Boston Heart Diagnostics, a US diagnostics laboratory focused on cardiometabolic health, where he served as Senior Vice President. Before that, he spent two decades at Genova Diagnostics, advancing from sales roles to vice-president-level positions across sales, marketing, and business development. Throughout his career, Watson has built and scaled commercial organizations in laboratory diagnostics and health technology, with responsibility for revenue strategy and execution across sales, marketing, commercial operations, market access, and customer experience, and has led new product launches in laboratory diagnostics and digital health.

At Nightingale Health, Watson is responsible for the company's commercial operations in the Americas. In building the business in the region, he works closely with management team member Janna Ranta, Chief Commercial Officer, Research and Healthcare.

"Throughout my career, I have built commercial organizations in laboratory diagnostics, and I am particularly drawn to companies where commercial execution must keep pace with scientific innovation. Nightingale Health is exactly that: technology validated at a scale our industry rarely sees, and a commercial opportunity in the Americas to match. I look forward to building it," says Hugh Watson, Chief Commercial Officer, Americas.

"Attracting a commercial leader of Hugh's caliber says a lot about where Nightingale Health is heading. He brings more than 25 years of commercial leadership in the US diagnostics industry and an entrepreneurial mindset that fits us perfectly. I warmly welcome Hugh to Nightingale Health," says Teemu Suna, CEO and Founder of Nightingale Health.